Description:
PharmGKB is a publicly available pharmaceutical research tool developed by Stanford University with funding from the National Institutes of Health (NIH) and is part of the NIH Pharmacogenomics Research Network (PGRN), a nationwide collaborative research consortium. Its aim is to aid researchers in understanding how genetic variation among individuals contributes to differences in reactions to drugs.